Come visit Diazyme’s booth at the upcoming BioConference Live virtual conference May 29 - 31, 2013. This online virtual conference is a great opportunity to attend talks from industry experts, earn CME and CE credits, chat with other attendees and learn more about the innovative solutions that Diazyme has to offer. Registration is simple and free. Just click here and come interact with thousands of other attendees in the clinical diagnostic space.

AACC Clinical Lab Expo will be held July 30-Aug. 1, 2013, at the George R. Brown Convention Center in Houston, Texas.

Feb 14, 2013
FDA Grants Diazyme 510(k) Clearance to Market Its D-Dimer Assay for Clinical Chemistry Analyzers

Jan 08, 2013
FDA Grants Diazyme 510(k) Clearance to Market its New 25-Hydroxy Vitamin D Enzyme Immunoassay

Nov 09, 2012
FDA Grants Diazyme Clearance to Market a New Biomarker for Early Detection of Kidney Disease, on the SMART Point of Care System

May 25, 2011
Diazyme Receives 510(k) FDA Approval for Enzymatic Glycated Serum Protein (Glycated Albumin) Assay Kit

Products A-Z

Products by Medical Condition

Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme’s products include test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, and electrolytes.

Diazyme Laboratories is a Division of General Atomics located in Poway, California and is a cGMP and ISO 13485 certified medical device manufacturer.